Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obesity Reports
Published in: Current Obesity Reports 3/2020

01-09-2020 | Obesity | Health Services and Programs (R Welbourn and C Borg, Section Editors)

Endoscopic Management of Clinically Severe Obesity: Primary and Secondary Therapeutic Procedures

Authors: Christine Stier, Ilja Balonov, Raphael Stier, Sonja Chiappetta, Carnina Teresa Fuss, Barham Abu Dayyeh

Published in: Current Obesity Reports | Issue 3/2020

Login to get access

Abstract

Purpose of Review

In the treatment of epidemic obesity and metabolic disorders, conservative approaches often fail to achieve the treatment goal in patients with very high BMI. To date, bariatric surgery accomplishes the most sustainable results in patients with morbid obesity. This leads to a treatment gap for lower and middle classes of obesity defined by BMI. Primary endoscopic procedures, which are less invasive than surgery, may be able to sufficiently fill this gap. Furthermore, secondary endoscopic procedures have developed into an essential addition regarding complication management of bariatric surgeries. The purpose of this review was to point out the latest developments in the field of bariatric endoscopy, including both primary and secondary procedures.

Recent Findings

Innovative devices and their possible applications will be discussed. These include various endoscopic suturing techniques as well as newly developed implants for the upper gastrointestinal tract to counteract the obesity epidemic.

Summary

The growing understanding of the pathophysiology of obesity and the role of the gastrointestinal tract allows for the development of more effective endoscopic procedures regarding obesity treatment.
Literature
1.
• Ginsberg GG, Chand B, Cote GA, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–53 Of importance.
2.
ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. Endoscopic bariatric therapies. GIE. 2015;81(5):1073–86.
3.
ASGE Bariatric Endoscopy Task Force, ASGE Technology Committee, Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015;82(3):425–38.
4.
ASGE Bariatric Endoscopy Task Force, Sullivan S, Kumar N, Edmundowicz SA, et al. ASGE position statement on endoscopic bariatric therapies in clinical practice. Gastrointest Endosc. 2015;82(5):767–72.
5.
Vargas EJ, Bazerbachi F, Calderon G, et al. Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;4 [Epub ahead of print].
6.
•• Galvao Neto M, Bezerra Silva L, Grecco E, et al. Brazilian Intragastric Balloon Consensus Statement (BIBC): practical guidelines based on experience of over 40,000 cases. Surg Obes Relat Dis. 2018;14:151–61 This reference gave new insights to the field or introduced officially the innovative techniques to daily clinical practice.
7.
Ponce J, Woodman G, Swain J, Wilson E, English W, Ikramuddin S, et al. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis. 2015;11:874–81.PubMed
8.
Genco E, Dellepiane D, Baglio G, et al. Adjustable intragastric balloon vs non-adjustable intragastric balloon: case-control study on complications, tolerance, and efficacy. Obes Surg. 2013;23(7):953–8.PubMed
9.
Usuy E, Brooks J. Response rates with the Spatz3 adjustable balloon. Obes Surg. 2018;28(5):1271–6.PubMed
10.
Sullivan S, Swain JM, Woodman G, et al. The Obalon swallowable 6-month balloon system is more effective than moderate intensity lifestyle therapy alone: results from a 6-month randomized sham controlled trial. Gastroenterology. 2016;150(4 Suppl. 1):S126.
11.
Sullivan S, Swain J, Woodman G, Edmundowicz S, Hassanein T, Shayani V, et al. Randomized sham-controlled trial of the 6-month swallowable gas-filled intragastric balloon system for weight loss. Surg Obes Relat Dis. 2018;14(12):1876–89.PubMed
12.
Moore RL, Seger MV, Garber SM, Smith AB, Nguyen RT, Shieh MK, et al. Clinical safety and effectiveness of a swallowable gas-filled intragastric balloon system for weight loss: consecutively treated patients in the initial year of U.S. commercialization. Surg Obes Relat Dis. 2019;15(3):417–23.PubMed
13.
Raftopoulos I, Giannakou A. The Elipse Balloon, a swallowable gastric balloon for weight loss not requiring sedation, anesthesia or endoscopy: a pilot study with 12-month outcomes. Surg Obes Relat Dis. 2019;13(7):1174–82.
14.
Machytka E, Gaur S, Chuttani R, et al. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy. 2017;49(2):154–60.PubMed
15.
Alsabah S, Al Haddad E, Ekrouf S, et al. The safety and efficacy of the procedureless intragastric balloon. Surg Obes Relat Dis. 2019;14(3):311–7.
16.
Genco A, Ernesti I, Ienca R. Safety and efficacy of a new swallowable intragastric balloon not needing endoscopy: early Italian experience. Obes Surg. 2018 Feb;28(2):405–9.PubMed
17.
Angrisani L, Santonicola A, Vitiello A, Belfiore MP, Belfiore G, Iovino P. Elipse Balloon: the pitfalls of excessive simplicity. Obes Surg. 2018;28:1419–21.PubMed
18.
19.
Thompson CC, Abu Dayyeh BK, Kushner R, Sullivan S, Schorr AB, Amaro A, et al. Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol. 2017;112(13):447–57.PubMed
20.
Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S. Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology. 2013;145(6):1245–52.PubMedPubMedCentral
21.
Aspiration therapy as a tool to treat obesity: 1- to 4-year results in a 201-patient multi-center post-market European Registry Study. Obes Surg 2018; 28(7): 1860–68.
22.
Sullivan S, Swain JM, Woodman G, Antonetti M, de la Cruz-Muñoz N, Jonnalagadda SS, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: the ESSENTIAL trial. Obesity. 2017;25:294–301.PubMed
23.
Khan Z, Khan MA, Hajifathalian K, et al. Efficacy of endoscopic interventions for the management of obesity: a meta-analysis to compare endoscopic sleeve gastroplasty, AspireAssist, and primary obesity surgery endoluminal. Obes Surg 2019 Jul;29(7):2287–2298.
24.
Bazerbachi F, Abu Dayyeh BK. The pressure is on! Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: toward better patient allocation beyond pygmalionism. Gastrointest Endosc. 2019;89(4):789–91.PubMed
25.
Storm AC, Abu Dayyeh BK. Endoscopic sleeve gastroplasty for obesity: defining the risk and reward after more than 1600 procedures. Gastrointest Endosc. 2019 Jun;89(6):1139–40.PubMed
26.
Abu Dayyeh BK, Neto MG, Lopez-Nava G, Sharaiha RZ, Kumbhari V, Wilson EB. Endoscopic sleeve gastroplasty is safe and effective: pitfalls of a flawed systematic review. Surg Obes Relat Dis. 2019;15(8):1423–5.PubMed
27.
Wallstabe I, Oberaender N, Weimann A, Schiefke I. Endoscopic sleeve gastroplasty using the novel Endomina device for morbidly obese patients. Endoscopy. 2018;50(11):E327–8.PubMed
28.
Jirapinyo P, Haas AV, Thompson CC. Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes. Diabetes Care. 2018 May;41(5):1106–15.PubMed
29.
Ruban A, Ashrafian H, Teare JP. The EndoBarrier: duodenal-jejunal bypass liner for diabetes and weight loss. Gastroenterol Res Pract. 2018 Jul 26;2018:7823182.PubMedPubMedCentral
30.
Leventi E, Günthert SJ, Stier C, et al. Is early reimplantation of the duodenal-jejunal bypass liner viable? Obes Surg. 2019;29(5):1690–3.PubMed
31.
Galvao Neto M, Rodriguez L, Becerra P, Mani S, Rothstein R. Hydrothermal duodenal mucosal resurfacing: a novel procedural therapy for metabolic disease. VideoGIE. 2016;1(1):10–1.PubMedPubMedCentral
32.
Haidry RJ, van Baar AC, Galvao Neto MP, Rajagopalan H, Caplan J, Levin PS, et al. Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting. Gastrointest Endosc. 2019;90(4):673–81.PubMed
33.
Younus H, Chakravartty S, Sarma DR, Patel AG. Endobarrier as a pre bariatric surgical intervention in high-risk patients: a feasibility study. Obes Surg. 2018;28(10):3020–7.PubMedPubMedCentral
34.
Ashrafian H, Monnich M, Braby TS, Smellie J, Bonanomi G, Efthimiou E. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series. Surg Obes Relat Dis. 2018;14(11):1691–9.PubMed
35.
Al-Sabah S, Al-Marri F, Vaz JD. Intragastric balloon as a bridge procedure in patients with high body mass index. Surg Obes Relat Dis. 2016;12(10):1900–1.PubMed
36.
Bazerbachi F, Haffar S, Sawas T, Vargas EJ, Kaur RJ, Wang Z, et al. Fluid-filled versus gas-filled intragastric balloons as obesity interventions: a network meta-analysis of randomized trials. Obes Surg. 2018;28(9):2617–25.PubMed
37.
Zorron R, Veltzke-Schlieker W, Adler A, Denecke C, Dziodzio T, Pratschke J, et al. Endoscopic sleeve gastroplasty using Apollo Overstitch as a bridging procedure for superobese and high risk patients. Endoscopy. 2018;50(1):81–3.PubMed
38.
•• ASGE EndoVators Taskforce, Ryou MQKR, Thompson CC, et al. EndoVators Summit: defining the role and value of endoscopic therapies in obesity management. Gastrointest Endosc. 2017;86(5):757–67 This reference gave new insights to the field or introduced officially the innovative techniques to daily clinical practice.
39.
Kuehn F, Schiffmann L, Rau BM, Klar E. Surgical endoscopic vacuum therapy for anastomotic leakage and perforation of the upper gastrointestinal tract. J Gastrointest Surg. 2012 Nov;16(11):2145–50.PubMed
40.
Kuehn F, Loske G, Schiffmann L, Gock M, Klar E. Endoscopic vacuum therapy for various defects of the upper gastrointestinal tract. Surg Endosc. 2017 Sep;31(9):3449–58.PubMed
41.
• Loske G, Müller CT. Tips and tricks for endoscopic negative pressure therapy. Der Chirurg. 2019;90(suppl 1):7–14 This reference influenced understanding of endoscopic bariatric therapy, based on pathophysiology, or optimized understanding of complication therapy by inducing a new, revolutionary therapy option.
42.
• Loske G. Endoscopic negative pressure therapy. Chirurg. 2019;(suppl 1):1–6 This reference influenced understanding of endoscopic bariatric therapy, based on pathophysiology, or optimized understanding of complication therapy by inducing a new, revolutionary therapy option.
43.
• Loske G, Schorsch T, Rucktaeschel F, Schulze W, Riefel B, van Ackeren V, et al. Open-pore film drainage (OFD) – a new multipurpose tool for endoscopic negative pressure therapy (ENPT). Endosc Int Open. 2018;6(7):E865–71 This reference influenced understanding of endoscopic bariatric therapy, based on pathophysiology, or optimized understanding of complication therapy by inducing a new, revolutionary therapy option.PubMedPubMedCentral
44.
Donatelli G, Fuks D, Tabchouri N, Pourcher G. Seal or drain? Endoscopic Management of Leaks Following Sleeve Gastrectomy. Surg Innov. 2018 Feb;25(1):5–6.PubMed
45.
Lorenzo D, Guilbaud T, Gonzalez JM, Benezech A, Dutour A, Boullu S, et al. Endoscopic treatment of fistulas after sleeve gastrectomy: a comparison of internal drainage versus closure. Gastrointest Endosc. 2018;87(2):429–37.PubMed
46.
Dammaro C, Lainas P, Dumont JL, et al. Endoscopic internal drainage coupled to prompt external drainage mobilization is an effective approach for the treatment of complicated cases of sleeve gastrectomy. Surg. 2019;29(9):2929–35.
47.
• Stier C, Chiappetta S. Endoluminal revision (OverStitch (TM) , Apollo Endosurgery) of the dilated gastroenterostomy in patients with late dumping syndrome after proximal Roux-en-Y gastric bypass. Obes Surg. 2016;26(8):1976–84 This reference influenced understanding of endoscopic bariatric therapy by creating innovative indications.
48.
•• Vargas EJ, Abu Dayyeh BK, Storm AC, et al. Endoscopic management of dumping syndrome after Roux-en-Y gastric bypass: a large international series and proposed management strategy [published online ahead of print, 2020 Feb 26]. Gastrointest Endosc. 2020:S0016–5107(20)30205–4. https://​doi.​org/​10.​1016/​j.​gie.​2020.​02.​029This reference gave new insights to the field or introduced officially the innovative techniques to daily clinical practice.
49.
Tsai C, Steffen R, Kessler U, et al. Short-term outcomes of endoscopic gastro-jejunal revisions for treatment of dumping syndrome after Roux-en-Y gastric bypass. Surg Endosc. 2019;24 [Epub ahead of print].
50.
Vargas E, Abu Dayyeh BK, Topazian M, et al. 1109 – Endoscopic management of late dumping syndrome: international series and proposed management strategy. Gastroenterology. 2019;156(6):S-237.
51.
Eid G. Sleeve gastrectomy revision by endoluminal sleeve plication gastroplasty: a small pilot case series.
52.
Hirdes MM, Vieggaar FP, de Beule M, et al. In vitro evaluation of the radial and axial force of self-expanding esophageal stents. Endoscopy. 2013;45(12):997–1005.PubMed
Metadata
Title
Endoscopic Management of Clinically Severe Obesity: Primary and Secondary Therapeutic Procedures
Authors
Christine Stier
Ilja Balonov
Raphael Stier
Sonja Chiappetta
Carnina Teresa Fuss
Barham Abu Dayyeh
Publication date
01-09-2020
Publisher
Springer US
Published in
Current Obesity Reports / Issue 3/2020
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-020-00385-y

Other articles of this Issue 3/2020

Current Obesity Reports 3/2020 Go to the issue

Health Services and Programs (R Welbourn and C Borg, Section Editors)

Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review

Obesity Epidemic (K Backholer and A Cameron, Section Editors)

The Retail Food Environment, Store Foods, and Diet and Health among Indigenous Populations: a Scoping Review

Metabolism (M Dalamaga, Section Editor)

Childhood Obesity and Cancer Risk in Adulthood

Metabolism (M Dalamaga, Section Editor)

The Implication of Gut Hormones in the Regulation of Energy Homeostasis and Their Role in the Pathophysiology of Obesity

Metabolism (M Dalamaga, Section Editor)

Autoantibody Production in Obesity: Is There Evidence for a Link Between Obesity and Autoimmunity?

Health Services and Programs (R Welbourn and C Borg, Section Editors)

Health-Related Quality of Life in Bariatric and Metabolic Surgery
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits